EU Regulators Find Wegovy, Ozempic Link to Rare Vision Loss

EU Regulators Find Wegovy, Ozempic Link to Rare Vision Loss
Above: The top three injectable prescription weight loss medicines: Ozempic, Victoza, and Wegovy, with a weight scale.  Image copyright:  Michael Siluk/Contributor/UCG/Universal Images Group via Getty Images

The Spin

Narrative A

These findings highlight safety signals that demand immediate attention from regulators and prescribers. The doubling of risk for severe eye conditions that can cause permanent blindness cannot be dismissed, even if the absolute numbers appear small. Patients deserve complete transparency about these risks before starting treatment.

Narrative B

These medications continue to provide tremendous benefits for diabetes management and weight loss that outweigh the rare potential complications. Regulatory agencies have appropriately classified these as very rare side effects while ensuring proper monitoring protocols are in place.

Metaculus Prediction


Articles on this story

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Sign Up!
Sign Up Now!